Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Saudi Medical Journal. 2008; 29 (3): 333-339
in English | IMEMR | ID: emr-90133

ABSTRACT

The interaction of natural products and drugs is a common hidden problem encountered in clinical practice. The interactions between natural products and drugs are based on the same pharmacokinetic and pharmacodynamic principles as drug-drug interactions. Clinically important interactions appear to involve effects on drug metabolism via cytochrome P-450 isoenzymes, impairment of hepatic or renal function, and other possible mechanisms. To effectively counsel patients on interactions involving natural products, physicians, and pharmacists should be familiar with the most commonly used products, and have access to information on more obscure products. In this review, we describe details of drugs interaction with natural products and its impact on drug therapy management


Subject(s)
Humans , Herb-Drug Interactions , Cytochrome P-450 Enzyme System , Citrus paradisi/adverse effects , Felodipine/pharmacokinetics , Terfenadine/pharmacokinetics , Itraconazole/pharmacokinetics , Cisapride/pharmacokinetics , Spinacia oleracea/adverse effects , Solanum lycopersicum/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics
2.
Rev. sanid. mil ; 54(5): 273-6, sept.-oct. 2000. CD-ROM
Article in Spanish | LILACS | ID: lil-292200

ABSTRACT

La cisaprida es hasta hoy el procinético intestinal de mayor uso en el mundo para el tratamiento de los trastornos de motilidad gastrointestinal, en México disponible de 1987 a la fecha, la farmacocinética y farmacodinámica han cobrado inusitada importancia al reportarse efectos adversos cardiacos potencialmente mortales (arritmias) principalmente con el uso combinado con medicamentos metabolizados por el citocromo P450 fracción 3 A4 en los que se incluye una larga lista de antibióticos, antimicóticos, antihistamínicos, antiarrítmicos etc, aún más el 24 de marzo de 2000 en Estados Unidos Janssen Pharmaceuticals y la FDA emitieron un comunicado para el uso restringido de la cisaprida. En nuestro país es posible que en un futuro cercano se haga lo mismo.


Subject(s)
Impacts of Polution on Health , Cisapride/adverse effects , Cisapride/pharmacokinetics , Gastrointestinal Motility/drug effects , Heart
3.
RNC ; 6(1): 29-31, mar. 1997.
Article in Spanish | LILACS | ID: lil-284348
SELECTION OF CITATIONS
SEARCH DETAIL